MoneyWorks4Me

Supriya Lifescience - Quaterly Results

03 Aug 2023 Evaluate
The Sales for the quarter ended June 2023 of Rs. 1320.21 millions rose by 30.26% from Rs. 1013.55 millions.A humble growth in net profit of 12.92% reported in the quarter ended June 2023 to Rs. 285.12  millions from Rs. 252.50 millions.Operating profit surged to 474.09 millions from the corresponding previous quarter of 336.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1320.21 1013.55 30.26 1320.21 1013.55 30.26 4609.38 5300.49 -13.04
Other Income 29.18 23.57 23.80 29.18 23.57 23.80 94.89 75.77 25.23
PBIDT 474.09 336.03 41.09 474.09 336.03 41.09 1383.87 2215.62 -37.54
Interest 8.16 5.81 40.45 8.16 5.81 40.45 30.84 41.98 -26.54
PBDT 465.93 330.22 41.10 465.93 330.22 41.10 1353.03 2173.64 -37.75
Depreciation 39.55 28.85 37.09 39.55 28.85 37.09 118.15 101.18 16.77
PBT 426.38 301.37 41.48 426.38 301.37 41.48 1234.88 2072.46 -40.41
TAX 141.26 48.87 189.05 141.26 48.87 189.05 336.30 554.35 -39.33
Deferred Tax 41.63 3.00 1287.67 41.63 3.00 1287.67 29.49 32.46 -9.15
PAT 285.12 252.50 12.92 285.12 252.50 12.92 898.58 1518.11 -40.81
Equity 160.97 160.96 0.01 160.97 160.96 0.01 160.97 160.97 0.00
PBIDTM(%) 35.91 33.15 8.31 35.91 33.15 8.31 30.02 41.80 -28.18
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..